Vitamin D3 for Life

Live Enlightened

Physiology

From a Vaccine Response to Immune Recall: What Vitamin D Studies Connect

Previous related pageVitamin D and Immune MemoryNext related pageVitamin D and Adaptive Immunity
Study at a glance

Does a higher antibody level after vaccination prove lasting protection?

Antibodies are proteins the immune system uses to recognise targets. A higher level after vaccination describes one part of the response at that time. It does not establish protection years later or the response to a future exposure.

Is a booster response the same as creating new immune memory?

No. A booster builds on earlier immune experience. Antibody levels and memory cells, which help the body respond again, are related but separate measurements.

Do these vitamin D studies prove stronger immune memory in people?

They do not establish a broad benefit. The studies used different vaccine timings, skin responses and animal models. A short-term change cannot stand in for demonstrated long-term protection.

Read the full article below ↓

A response after vaccination and a response to something encountered years earlier are related, but they answer different questions. Vitamin D studies become easier to interpret when the stages are kept separate: an initial response, a later recall response, and persistence over time. This page connects those stages without treating one measurement as proof of the others.

From the first encounter to a later response

Vitamin D and Adaptive Immunity introduces the targeted immune system. An antigen is a substance recognised by that system. Researchers can measure antibodies during a vaccine course, but that result describes the response at the testing point. It does not establish how the person will respond after a long interval or whether protection will persist.

Kashi and colleagues’ hepatitis B trial illustrates the timing problem. Vitamin D treatment started after the first vaccine dose, and antibodies were assessed before the final dose of the course. The study therefore cannot answer every question about vitamin D before first exposure or after a completed course. Its finding that did not show a treatment benefit still matters for the actual conditions tested. Untested timing is a gap, not evidence of a benefit at another time.

A booster tests an existing immune history

A booster is an additional vaccine dose given after earlier vaccination. Heine and colleagues’ small tetanus study found a difference in one antibody measure after a booster, without matching benefits in measured memory B cells or several other outcomes. Memory B cells retain information relevant to a later response. Their frequency and the amount of circulating antibody are related but different measurements.

The study did not follow people for five or ten years. A statement about an antibody threshold associated with longer protection should not be mistaken for observed long-term follow-up. The distinction connects a short-term booster result with the larger persistence question while making clear that the latter remains unresolved.

The tissue environment matters to the measured response

Chambers and colleagues examined a skin response to varicella-zoster antigen in older adults before and after vitamin D replacement. The clinical skin response improved overall, with individual variation. The study had no randomised placebo group, so it could not securely isolate the treatment effect. Nor did the result establish protection against shingles.

This supplies a link to Vitamin D and Immune Ageing: a response to previous immune experience is expressed in a tissue environment that may change with age. It does not show that every part of immune memory has improved. Early defence, introduced in Vitamin D and Innate Immunity, also interacts with targeted responses, but an innate marker is not itself a measure of antigen-specific memory.

A longer observation does not remove the model boundary

Yuzefpolskiy’s mouse experiment followed memory-related responses to a later time point and found reduced response diversity in animals lacking the vitamin D receptor. A receptor is a protein through which a signal acts. Removing it throughout a mouse’s life is different from supplementing a person whose blood vitamin D is low. The longer animal observation cannot be relabelled a human supplementation result.

Together, these examples show the connection and the gap. First responses can lead to later recall, and recall can be studied during ageing. But evidence at one stage does not automatically establish an effect at every later stage. The detailed comparison is in Vitamin D, Immune Memory Formation and Recall Across Age: Full Evidence Review.

Sources

Related reading

Library

The Expressions of the Immunity: and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the In Ovo and Dietary Supplemental Administration of Calcidiol in Conjunction with the In Ovo Administration of Marek’s Disease Vaccine †

The purpose of the current study was to identify the impacts of supplemental 25(OH)D3 administered dietarily or by in ovo injection in conjunction with the in ovo delivery of Marek’s Disease vaccine (MVD), on the expression of genes in the spleen and pectoralis major (P.

Original paper ↗Read more →

Original sources

Source

Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults

Kashi et al. (2021). Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults.

Publication details

Kashi et al. (2021). Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D3 and simulated sunlight supplementation trial in healthy adults. European Journal of Nutrition. 60(1):475. DOI: 10.1007/s00394-020-02261-w.

Read more →